publication venue for
- Exploring the potential harm of varied blood storage on patients undergoing cardiovascular surgery 2023
- Sex‐mismatched red blood cell transfusions and mortality: A systematic review and meta‐analysis 2019
- BENCHMARKING: APPLICATIONS TO TRANSFUSION MEDICINE 2013
- CLINICAL TRIALS ON PLATELET TRANSFUSION: SUCCESSES AND FAILURES 2013
- The International Registry of Immune Tolerance: 1994 Update 1996
- A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion‐Transmitted Injuries Surveillance System (Ontario). 118:753-762. 2023
- A positive blood culture is associated with a lower haemoglobin increment in hospitalized patients after red blood cell transfusion. 118:33-40. 2023
- A cross‐sectional study of haemolytic disease of the newborn in Uganda. 117:1398-1404. 2022
- Plasma transfusion practices: A multicentre electronic audit. 117:1211-1219. 2022
- Babesia microti in a Canadian blood donor and lookback in a red blood cell recipient. 117:438-441. 2022
- Challenging the 30‐min rule for thawed plasma. 117:328-336. 2022
- Vox Sanguinis International Forum on Donor Incentives. 115:e1-e18. 2020
- Vox Sanguinis International Forum on Donor Incentives: Summary. 115:339-344. 2020
- Not all red cell concentrate units are equivalent: international survey of processing and in vitro quality data. 114:783-794. 2019
- Canadian expert consensus: management of hypersensitivity reactions to intravenous iron in adults. 114:363-373. 2019
-
Maternal
HPA ‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review. 114:79-94. 2019 - A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy. 113:251-259. 2018
- Bacteria can proliferate in thawed cryoprecipitate stored at room temperature for longer than 4 h. 112:477-479. 2017
- Comparison of bacterial attachment to platelet bags with and without preconditioning with plasma. 112:401-407. 2017
-
Early γ‐irradiation and subsequent storage of red cells in
SAG ‐M additive solution potentiate energy imbalance, microvesiculation and susceptibility to stress‐induced apoptotic cell death. 112:480-483. 2017 -
Group O
RBC s: where is universal donor blood being used. 112:336-342. 2017 - Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta‐analysis. 112:268-278. 2017
- Transfusion‐related alloimmunization in children: epidemiology and effects of chemotherapy. 111:299-307. 2016
- Reducing the age of transfused red blood cells in hospitals: ordering and allocation policies. 110:385-392. 2016
- Safety of lumbar punctures in patients with thrombocytopenia. 110:393-400. 2016
- Stability of coagulation protein activities in single units or pools of cryoprecipitate during storage at 20–24°C for up to 24 h. 110:12-19. 2016
- Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study. 108:274-280. 2015
- Implementation and public acceptability: lessons from food irradiation and how they might apply to pathogen reduction in blood products. 107:50-59. 2014
- Counting platelets at transfusion threshold levels: impact on the decision to transfuse. A BEST Collaborative ‐ UK NEQAS(H) International Exercise. 106:330-336. 2014
- Lipoprotein enrichment in orange insoluble particulate matter reproducibly appearing in cryoprecipitate. 100:422-425. 2011
- A pilot study of the possibility and the feasibility of haemoglobin dosing with red blood cells transfusion. 99:71-76. 2010
- Coombs' crossmatch after negative antibody screening--a retrospective observational study comparing the tube test and the microcolumn technology.. 98:e269-e275. 2010
- Coombs’ crossmatch after negative antibody screening - a retrospective observational study comparing the tube test and the microcolumn technology. 98:e269-e275. 2010
- Clinical and laboratory practices in investigation of suspected transfusion‐transmitted bacterial infection: a survey of Canadian hospitals. 96:157-159. 2009
- Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura. 93:173-175. 2007
- Pathogen inactivation: making decisions about new technologies – preliminary report of a consensus conference. 93:179-182. 2007
- Risk factors for red cell transfusion in adults undergoing coronary artery bypass surgery: a systematic review. 93:1-11. 2007
- Evidence‐based decision making in transfusion medicine. 91:214-220. 2006
- An international study of the performance of sample collection from patients. 85:40-47. 2003
- Clinical Expertise in the Era of Evidence‐Based Medicine and Patient Choice (editorial). 83:383-386. 2002
- Clinical Research Designs: Quantitative Studies. 83:247-250. 2002
- The Use and Quality Control of Leukocyte‐Depleted Cell Concentrates. 75:84-85. 1998
- Haemophilia in the 1990s: Report of a Joint Meeting of the World Health Organization and World Federation of Hemophilia. 61:221-224. 1991
- Use of Plasma Segments for Estimating Factor VIII Activity in Pools of Fresh Frozen Plasma. 52:254-256. 1987
- Use of Segments for the Quality Control of the Factor VIII: Coagulant Activity of Fresh Frozen Plasma. 48:213-216. 1985
- Assessment of Methods for Cytomegalovirus Antibody Testing of Blood Donations. 47:343-347. 1984
- The HL‐A Type of Rg(a–) Individuals. 30:214-216. 1976
- Selective IgA Deficiency in Rh‐Negative Women. 27:87-91. 1974